Market Dynamics on December 20th
I. Macro Trends
1. Market trend: The market is oscillating sideways.
2. U.S stocks are rising, and U.S housing market data supports a soft landing for the economy.
II. Market Highlights
1. NEON and SEI in the EVM track have surged significantly due to speculation on parallel EVM concepts which are more efficient than serial ones, mainly catalyzed by too much spam caused by inscriptions.
2. Inscription GWEI, LAMP, BITMAP's blue boxes have soared as the market speculates on ETH and SOL chain inscriptions' second dragons.
3. COQ and DOGE-1 from Meme track continue to lead gains; COQ is Avax's chicken while DOGE-1 is ETH chain's dog - a bull run of both dogs and chickens.
4. HONEY and MOBILE from Depin collapsed as the market speculated on tail-end asset data; several leading figures of Solana’s Depin were halved after reaching their peak.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Delta Air Lines expects fourth-quarter revenue to grow by 20% year-on-year
Delta Air Lines (DAL.US) expects fourth-quarter revenue to increase by 20% year-on-year, with capacity growing by about 3%.
U.S. stocks movement | Federal Medicare Advantage Plan ratings greatly improved, Humana (HUM.US) surged nearly 12%
According to information from Zhitong Finance APP, on Friday, Humana (HUM.US) shares surged as much as 18% in early trading and were up nearly 12% at $433.07 at the time of reporting. Humana disclosed that 95% of relevant insured members have entered plans rated four stars or above. Based on the final Medicare Advantage Plan star ratings for 2027, Humana expects the average monthly star rating revenue per member to reach $160 by 2027. The company stated that this performance has exceeded its "top quartile" target, which is 10% higher than the industry average. Humana reaffirmed its guidance for adjusted earnings per share of at least $9 for fiscal year 2026.
Moderna officially included in the Nasdaq 100 Index, surges nearly 9% intraday
Moderna surged intraday, now up nearly 9%, reaching its highest stock price since December 2022. The company was officially included in the Nasdaq 100 index today.
【US Stock Market Movement】Circle surged on October 9: SAP payments + USDC expansion + stablecoins